Kassem Faraj1, Florence Doo1, Judy Boura2, Andrew Vereecke2, Michael B Chancellor3,4. 1. Oakland University William Beaumont School of Medicine, Rochester, MI, USA. 2. Beaumont Health System, Royal Oak, MI, USA. 3. Oakland University William Beaumont School of Medicine, Rochester, MI, USA. Michael.Chancellor@beaumont.edu. 4. Beaumont Health System, Royal Oak, MI, USA. Michael.Chancellor@beaumont.edu.
Abstract
PURPOSE: To assess the prevalence, awareness, and quality of life (QOL) impact of symptoms suggestive of underactive bladder (UAB) in the USA. METHODS: A thirteen-item paper survey was mailed to 25,000 individuals 60 years or older living in the USA. It aimed to collect information relating to demographics, familiarity with UAB, patient urinary symptoms, and QOL concerns. RESULTS: Nine hundred and seventy-seven survey participants were stratified into four groups based on the number of UAB symptoms (straining, retention, and difficulty emptying) present: zero, one, two, and three. As the number of reported UAB symptoms increased, there was an increase prevalence in nocturia, urge, and urinary frequency (p < 0.0001). Increased UAB symptoms were associated with an increased prevalence of concerns related to urgency, urge incontinence, nocturia, and overall urinary status (p < 0.0001). Urology visits were most common in individuals who reported the most UAB symptoms (p < 0.0001); however, there was no difference among groups with regard to UAB awareness. Women were less likely to report any UAB symptoms (p < 0.0001), symptoms of urge (p = 0.001), retention (p = 0.002), difficulty emptying their bladder (p < 0.0001), a history of catheter use for retention (P = 0.002), and urology visits in the past 3 years (p < 0.0001). This study is limited in its inability to differentiate UAB from disorders that may mimic UAB clinically, based on the survey questions asked. CONCLUSIONS: Underactive bladder symptoms are common and can have a significant impact on ones QOL, although awareness is still lacking among potentially affected individuals. More must be done to allow one to better differentiate between UAB and conditions that are clinically similar.
PURPOSE: To assess the prevalence, awareness, and quality of life (QOL) impact of symptoms suggestive of underactive bladder (UAB) in the USA. METHODS: A thirteen-item paper survey was mailed to 25,000 individuals 60 years or older living in the USA. It aimed to collect information relating to demographics, familiarity with UAB, patient urinary symptoms, and QOL concerns. RESULTS: Nine hundred and seventy-seven survey participants were stratified into four groups based on the number of UAB symptoms (straining, retention, and difficulty emptying) present: zero, one, two, and three. As the number of reported UAB symptoms increased, there was an increase prevalence in nocturia, urge, and urinary frequency (p < 0.0001). Increased UAB symptoms were associated with an increased prevalence of concerns related to urgency, urge incontinence, nocturia, and overall urinary status (p < 0.0001). Urology visits were most common in individuals who reported the most UAB symptoms (p < 0.0001); however, there was no difference among groups with regard to UAB awareness. Women were less likely to report any UAB symptoms (p < 0.0001), symptoms of urge (p = 0.001), retention (p = 0.002), difficulty emptying their bladder (p < 0.0001), a history of catheter use for retention (P = 0.002), and urology visits in the past 3 years (p < 0.0001). This study is limited in its inability to differentiate UAB from disorders that may mimic UAB clinically, based on the survey questions asked. CONCLUSIONS: Underactive bladder symptoms are common and can have a significant impact on ones QOL, although awareness is still lacking among potentially affected individuals. More must be done to allow one to better differentiate between UAB and conditions that are clinically similar.
Authors: Tomas L Griebling; Catherine E DuBeau; George Kuchel; Mary H Wilde; Michelle Lajiness; Hikaru Tomoe; Ananias Diokno; Andrew Vereecke; Michael B Chancellor Journal: Int Urol Nephrol Date: 2014-09-20 Impact factor: 2.370
Authors: Seong Jin Jeong; Hyeon June Kim; Young Ju Lee; Jeong Keun Lee; Byung Ki Lee; Young Min Choo; Jong Jin Oh; Sang Cheol Lee; Chang Wook Jeong; Cheol Yong Yoon; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee Journal: Korean J Urol Date: 2012-05-18
Authors: Michelle Yu; Jamie Uy; Xuewen Jiang; Xing Li; Cameron Jones; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai Journal: Am J Physiol Renal Physiol Date: 2017-08-30
Authors: Shun Li; Katherine Theisen; Jeffery Browning; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai Journal: Neurourol Urodyn Date: 2018-04-10 Impact factor: 2.696
Authors: Katherine Theisen; Jeffery Browning; Xing Li; Shun Li; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai Journal: Neuromodulation Date: 2018-06-27